Anticoagulant Citrate Dextrose Solution Formula A (ACD-A) Drug Information - Guideline Central

ACD-A (Anticoagulant Citrate Dextrose Solution Formula A) solution

Fenwal, Inc.
Fenwal, Inc.
Fenwal, Inc.
Baxter Healthcare Corporation
ACD-A
Anticoagulant Citrate Dextrose Solution Formula A
Dextrose Monohydrate
ANHYDROUS DEXTROSE
SODIUM CITRATE, UNSPECIFIED FORM
Anhydrous Citric Acid
Anhydrous Citric Acid
Anhydrous Citric Acid
Water

Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A

CAUTION–

DO NOT REMOVE UNIT FROM OVERWRAP UNTIL READY FOR USE
THE OVERWRAP IS A MOISTURE BARRIER
THE INNER BAG MAINTAINS THE STERILITY OF THE PRODUCT
STORE AT CONTROLLED ROOM TEMPERATURE

CODE 4B7898Q
NDC 0942-0641-03

500 mL

Fenwal™

Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A

EACH 100 mL CONTAINS 2.45 g DEXTROSE (MONOHYDRATE) USP 2.2 g SODIUM CITRATE (DIHYDRATE) USP 730 mg CITRIC ACID (ANHYDROUS) USP

STERILE , NONPYROGENIC

STERILIZED BY STEAM

SINGLE USE CONTAINER

DISCARD UNUSED PORTION

FOR USE WITH CYTAPHERESIS DEVICE ONLY

NOT FOR DIRECT INTRAVENOUS INFUSION

DO NOT USE UNLESS SOLUTION IS CLEAR AND NO LEAKS ARE DETECTED

AFTER REMOVING OVERWRAP CHECK FOR MINUTE LEAKS BY SQUEEZING INNER BAG FIRMLY

IF LEAKS ARE FOUND DISCARD SOLUTION AS STERILITY MAY BE IMPAIRED

DISPOSE OF CONTAINER APPROPRIATELY

SEE CARTON FOR ADDITIONAL PRODUCT AND COUNTRY SPECIFIC INFORMATION

Rx only

PL 146 PLASTIC

Manufactured by:
Baxter Healthcare Corporation
65 Pitts Station Road
Marion, North Carolina 28752

MADE IN USA 07-25-57-867 REV: B

Manufactured for:

logo
Fenwal, Inc.
Lake Zurich, IL 60047 USA

logo

PACKAGE/LABEL DISPLAY PANEL

Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A label
[Enter Package/Label Display Panel here]

Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A label
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.